Results 31 to 40 of about 699,373 (191)
Purpose The aim of this study was to evaluate the effect of preoperative subconjunctival bevacizumab injection on the clinical and immunohistochemical analysis of primary pterygium.
Abd Elmagid M Tag Eldin +2 more
doaj +1 more source
Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema [PDF]
Background: Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. Methods and Materials: A collective of 32 patients, who had been treated
Haritoglou, Christos +6 more
core +1 more source
Introduction: Normally the cornea in human eye is crystalline clear membranepresent in the anterior most portion of the eyeball. Regarding the various functions of thecornea in human eye it provides protection, clear vision, refractive media the visual systemand maintains itself as an immune privileged site.
Dr. Faheem Ahmad, Dr. Tayyab Mushtaq
openaire +2 more sources
Purpose The aim of this study was to assess the efficacy of subconjunctival bevacizumab injection as adjuvant therapy in the prevention of recurrence following excision of pterygium and application of sutureless gluefree conjunctival autograft (SL/GF CAG)
Mona M Aly +2 more
doaj +1 more source
PurposeTo investigate the effect and timing of subconjunctival bevacizumab injection on inhibiting corneal neovascularization (CorNV) in patients after chemical burns.MethodsPatients with CorNV secondary to chemical burns were involved.
Wen-yan Peng +5 more
doaj +1 more source
Drug Delivery Technologies for the Treatment of Age-Related Macular Degeneration. [PDF]
There are multiple therapeutic agents available for the treatment of both dry age‐related macular degeneration (AMD) and wet AMD. It is essential to continue innovation by introducing new drug delivery technologies that can incorporate those along with patient compliance and the accessibility of the technology into the early stages of research and ...
Rodriguez-Cruz JJ +5 more
europepmc +2 more sources
Subconjunctival bevacizumab injection versus mitomycin C application after primary pterygium surgery
Purpose The aim of this study was to compare subconjunctival bevacizumab injection and mitomycin C (MMC) application after primary pterygium surgery in terms of recurrence rates and complications.
Hani A Albialy, Haitham Y Al-Nashar
doaj +1 more source
Effects of Subconjunctival Bevacizumab Injection after Primary Pterygium Surgery
Purpose: This study evaluated the efficacy and safety of subconjunctival bevacizumab injection after primary pterygium surgery.Methods: We performed a conjunctivo-limbal autograft after pterygium resection in 136 eyes of 128 patients with primary pterygium between December 2019 and July 2021.
Eunyu Yoon, Minji Park, Jaewon Choi
openaire +1 more source
Subconjunctival Bevacizumab Injection in Treatment of Recurrent Pterygium [PDF]
Objective: To determine the clinical effect of subconjunctival injection of bevacizumab in regression or halting growth in patients with recurrent pterygium.Method and materials: The study was an off-label; 2-dosing, interventional case series involving 20 patients with recurrent pterygium.
openaire +1 more source
الملخص: أهداف البحث: الظفرة هي كتلة العين الخارجية الليفية الوعائية التي تنمو من الملتحمة إلى القرنية. لم يتم التحقيق في تأثير الحقن تحت الملتحمة لتريامسينولون وبيفاسيزوماب بشكل كاف في جميع أنحاء العالم.
Purnamanita Syawal, PhD +5 more
doaj +1 more source

